Association between implanted cardioverter-defibrillators and mortality for patients with left ventricular ejection fraction between 30% and 35%

BACKGROUND: Consensus guidelines support the use of implanted cardioverter-defibrillators (ICD) for primary prevention of sudden cardiac death in patients with either non-ischaemic or ischaemic cardiomyopathy with left ventricular ejection fraction (LVEF) ≤35%. However, evidence from trials for effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wasfy, Jason H, Achanta, Aditya, Hidrue, Michael K, Urbut, Sarah, Axtell, Andrea L, Berman, Adam N, Zhao, Yunong, Chen, Julian, Gustus, Sarah, Picard, Michael H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462974/
https://www.ncbi.nlm.nih.gov/pubmed/37625819
http://dx.doi.org/10.1136/openhrt-2023-002289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462974/
https://www.ncbi.nlm.nih.gov/pubmed/37625819
http://dx.doi.org/10.1136/openhrt-2023-002289

Ejemplares similares